The protein tyrosine phosphatase, non-receptor type 11 (PTPN11) gene encodes SHP-2, a phosphatase involved in many signaling pathways, with a key role in development and hematopoiesis. Somatic PTPN11 mutations were found with variable prevalences in pediatric leukemia, most frequently associated with juvenile myelomonocytic leukemia (JMML).1,2 In vitro and in vivo studies, mainly in a myeloid context, demonstrated a crucial involve- ment of PTPN11 mutations in the hyperactivation of the RAS/ERK pathway.3 The oligoclonality of transgene integration sites, and the long latency before overt leukemia in mice transduced with mutant PTPN11,3 suggested that additional molecular lesions are needed to cooperate with PTPN11 mutations in leukemogenesis. This observation is in line with the ‘two hit model’ proposed by Greaves4 for B-cell precursor childhood acute lymphoblastic leukemia (ALL), in which an initiating alteration, often occurring prenatally, gives rise to a preleukemic clone, which eventually becomes fully malignant by subsequent acquisition of other molecular alterations.

PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy / Molteni, Cg; Te Kronnie, G; Bicciato, Silvio; Villa, T; Tartaglia, M; Basso, G; Biondi, A; Cazzaniga, G.. - In: LEUKEMIA. - ISSN 0887-6924. - STAMPA. - 24(1):(2010), pp. 232-235. [10.1038/leu.2009.200]

PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy

BICCIATO, Silvio;
2010

Abstract

The protein tyrosine phosphatase, non-receptor type 11 (PTPN11) gene encodes SHP-2, a phosphatase involved in many signaling pathways, with a key role in development and hematopoiesis. Somatic PTPN11 mutations were found with variable prevalences in pediatric leukemia, most frequently associated with juvenile myelomonocytic leukemia (JMML).1,2 In vitro and in vivo studies, mainly in a myeloid context, demonstrated a crucial involve- ment of PTPN11 mutations in the hyperactivation of the RAS/ERK pathway.3 The oligoclonality of transgene integration sites, and the long latency before overt leukemia in mice transduced with mutant PTPN11,3 suggested that additional molecular lesions are needed to cooperate with PTPN11 mutations in leukemogenesis. This observation is in line with the ‘two hit model’ proposed by Greaves4 for B-cell precursor childhood acute lymphoblastic leukemia (ALL), in which an initiating alteration, often occurring prenatally, gives rise to a preleukemic clone, which eventually becomes fully malignant by subsequent acquisition of other molecular alterations.
2010
24(1)
232
235
PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy / Molteni, Cg; Te Kronnie, G; Bicciato, Silvio; Villa, T; Tartaglia, M; Basso, G; Biondi, A; Cazzaniga, G.. - In: LEUKEMIA. - ISSN 0887-6924. - STAMPA. - 24(1):(2010), pp. 232-235. [10.1038/leu.2009.200]
Molteni, Cg; Te Kronnie, G; Bicciato, Silvio; Villa, T; Tartaglia, M; Basso, G; Biondi, A; Cazzaniga, G.
File in questo prodotto:
File Dimensione Formato  
Molteni_et_al_2010.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 160.59 kB
Formato Adobe PDF
160.59 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/639872
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 14
social impact